Skip to main content
Clinical Trials/NCT05311137
NCT05311137
Recruiting
Not Applicable

Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community

Shanghai 10th People's Hospital1 site in 1 country5,000 target enrollmentMay 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Shanghai 10th People's Hospital
Enrollment
5000
Locations
1
Primary Endpoint
Atrial fibrillation recurrence
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.

Detailed Description

This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy, the improvement of disease outcome and the economic value of the atrial fibrillation population in the northern Shanghai community. Improve the disease cognition of patients with atrial fibrillation, and promote the development of the concept of closed-loop treatment of atrial fibrillation.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
January 1, 2032
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai 10th People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ya-Wei Xu

Director, Director of Cardiovascular Medicine

Shanghai 10th People's Hospital

Eligibility Criteria

Inclusion Criteria

  • atrial fibrillation patients;Ability to act autonomously, understand and sign informed consent;

Exclusion Criteria

  • none(All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up)

Outcomes

Primary Outcomes

Atrial fibrillation recurrence

Time Frame: 2 years

The recurrence of atrial fibrillation and the degree of burden of atrial fibrillation in patients.

Stroke

Time Frame: 5 years

stroke attack(Check for new cerebral infarction by MRI)

Heart failure

Time Frame: 5 years

Degree of heart failure (including EF%, NYHA score, etc.)

Secondary Outcomes

  • bleeding(2 years)
  • Cardiovascular MACE events(5 years)

Study Sites (1)

Loading locations...

Similar Trials